size of 3 mm3, smoothed with an 8 mm full-width half-maximum Gaussian kernel using SPM 5. The GLM approach implemented in SPM 5 was utilized for fMRI data modeling and analyses. Each epoch type (zero-back, two-back and rest) was modeled in a boxcar design, using a canonical hemodynamic response function and its temporal derivative. The single group second level analysis consisted of voxelwise one-sample t-tests with significance threshold set at voxel level p < .05, false discovery rate (FDR) corrected for multiple comparisons across the entire brain. The between-group comparison employed voxelwise two sample t-tests with the significance criterion based on the spatial extent of suprathreshold voxel clusters, a method proposed by (Friston et al., 1994). The criterion for inclusion of a voxel in a cluster was set at p < .05 (uncorrected) and a cluster was considered as significant at level of p < .05 (corrected). Results: Patients exhibited relatively high general function and mild symptoms, but had significantly longer reaction time and decline in performance. Both controls and patients activated similar set of brain regions similar to Central executive network and deactivated brain areas comprising the default mode network. Most noteworthy, we did not find evidence for hypofrontality (reduced activity in DLPFC in patients compared to controls) in this study. Compared to controls, patients showed areas of greater activation in left postcentral gyrus, anterior and posterior medial frontal gyrus and left superior temporal gyrus. Discussion: Both controls and patients showed activation in widespread brain areas consistent with the CEN, and deactivation in areas consistent with DMN regions. There was no evidence of hypofrontality in this sample of remitted people with schizophrenia. Patients showed activation patterns on the zeroback task similar to the activation patterns for controls on the two back task, suggesting that patients showed increased brain activation on a task with lesser requirements, though behavioural results suggest inefficiency despite the increased effort. Background: The pre-TIPS study in 1994-95 showed that the duration of untreated psychosis (DUP) was long in our region with a mean value of 2.1 years, and median 26 weeks. This set the stage for the TIPS-study (1997)(1998)(1999)(2000), reducing DUP through information campaigns targeted to the general population and other referral agents (GP's, schools and others) in Rogaland County (Norway). The information campaigns were launched together with a low threshold organization with direct access to an early detection team, for a diagnostic interview and help. The hypothesis was that this could change help seeking behavior, awareness towards psychosis and thus reduce the DUP. The information campaigns and the early detection team were introduced in an early detection(ED) area (Rogaland county, Norway) comparing DUP with two usual-detection control sites in Oslo (Norway) and Roskilde (Denmark). As a result, DUP in the early detection area was reduced from 26 weeks median to 4 weeks median. Symptom and function advantages of early detection and DUP reduction have been demonstrated as being significant throughout the follow-up period. Social and functional outcome have been increasingly emphasized as being key parameters, as these contribute to both quality of life and to financial costs in society. The TIPS program continues to include and follow patients; since the mid 2000's also young people with ultra-high risk states (Prevention of Psychosis; POP) or substance induced psychoses. Previous ultra-high risk studies suggest that psychotic disorders are associated with structural and functional abnormalities within the frontoparietal circuits and that medication status is a potential confounding factor.
F163. STRUCTURAL AND FUNCTIONAL ALTERATIONS IN THE BRAIN DURING WORKING MEMORY IN MEDICATION-NAÏVE PATIENTS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
Background: The pre-TIPS study in 1994-95 showed that the duration of untreated psychosis (DUP) was long in our region with a mean value of 2.1 years, and median 26 weeks. This set the stage for the TIPS-study (1997) (1998) (1999) (2000) , reducing DUP through information campaigns targeted to the general population and other referral agents (GP's, schools and others) in Rogaland County (Norway). The information campaigns were launched together with a low threshold organization with direct access to an early detection team, for a diagnostic interview and help. The hypothesis was that this could change help seeking behavior, awareness towards psychosis and thus reduce the DUP. The information campaigns and the early detection team were introduced in an early detection(ED) area (Rogaland county, Norway) comparing DUP with two usual-detection control sites in Oslo (Norway) and Roskilde (Denmark). As a result, DUP in the early detection area was reduced from 26 weeks median to 4 weeks median. Symptom and function advantages of early detection and DUP reduction have been demonstrated as being significant throughout the follow-up period. Social and functional outcome have been increasingly emphasized as being key parameters, as these contribute to both quality of life and to financial costs in society. The TIPS program continues to include and follow patients; since the mid 2000's also young people with ultra-high risk states (Prevention of Psychosis; POP) or substance induced psychoses. Previous ultra-high risk studies suggest that psychotic disorders are associated with structural and functional abnormalities within the frontoparietal circuits and that medication status is a potential confounding factor.
We investigated neural correlates to ultra-high risk (UHR) for psychosis in medication-naïve patients. Methods: 41 CHR patients and 37 healthy controls were examined with 1. Background: Negative symptoms are a core feature of schizophrenia and also found in healthy individuals in subclinical forms. According to the current literature the two negative symptom domains, apathy and diminished expression may have different underlying neural mechanisms. Previous observations suggest that striatal dysfunction is associated with apathy in schizophrenia. However, it is unclear whether apathy is specifically related to ventral or dorsal striatal alterations. Here, we investigated striatal dysfunction in patients with schizophrenia and a nonclinical population, to determine whether it is a relevant neural correlate for apathy. Methods: Chronic schizophrenia patients (n= 16) and healthy controls (n=23) underwent an event-related functional MRI, while performing a variant of the Monetary Incentive Delay Task. The two negative symptom domains were assessed in both groups using the Brief Negative Symptoms Scale. Results: In schizophrenia patients, we saw a strong negative correlation between apathy and ventral and dorsal striatal activation during reward anticipation. In contrast, there was no correlation with diminished expression. In healthy controls, global negative symptoms were correlated with decreased dorsal striatal activity. Discussion: This study replicates our previous findings of a correlation between ventral striatal activity and apathy but not diminished expression in chronic schizophrenia patients. The association between apathy and reduced dorsal striatal activity suggests that impaired action-outcome selection is involved in the pathophysiology of motivational deficits. Finally, our findings in healthy controls support the idea that striatal alterations are a plausible neural correlate for negative symptoms in both a clinical and a subclinical context. 
